Sound Income Strategies’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
Other funds holding SYRS
BBA
1CM
XT
Sound Income Strategies's SYRS Position: Q1 2025 in Review
Sound Income Strategies sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2025, closing a stake of 76 shares — an estimated $17 sold.
Sound Income Strategies first reported a position in SYRS in Q1 2023 and held it in 8 quarters. The position peaked at $592 in Q4 2023. 7 funds tracked by Wall St. Rank hold SYRS as of Q1 2025.
- Sound Income Strategies reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Sound Income Strategies sold 76 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $17.
- Sound Income Strategies first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 8 quarters.
- Sound Income Strategies's Syros Pharmaceuticals, Inc. Common Stock position peaked at $592 in Q4 2023.
- 7 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2025.
Based on Sound Income Strategies's 13F filing for Q1 2025, filed 17 Apr 2025.